A decade-long path of industrial evolution and environmental responsibility, from the first photovoltaic system to ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for TransCon ® CNP (navepegritide) for the treatment of children with achondroplasia ...

TransCon CNP is an investigational prodrug of C-type natriuretic peptide (CNP) administered once weekly and designed to treat people living with achondroplasia by providing continuous exposure of ...

Results demonstrated that TransCon hGH boosted treatment benefits of TransCon CNP, resulting in significant growth and proportionality improvements in children with achondroplasia after 26 weeks ...

Omnichannel payment orchestration is the glue that holds online, in-store, mobile and IoT transactions together in a single ...

Microblink now provides comprehensive Card-Not-Present fraud protection within an end-to-end identity orchestration framework ...

For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over ...

Based in Houston, CenterPoint Energy (CNP) is in the Utilities sector, and so far this year, shares have seen a price change of 16.96%. The energy delivery company is paying out a dividend of $0. ...

CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The company operates in Electric and Natural Gas segments. The Electric segment provides electric ...